These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 17963413)

  • 1. Single-step process to produce surface-functionalized polymeric nanoparticles.
    Sussman EM; Clarke MB; Shastri VP
    Langmuir; 2007 Nov; 23(24):12275-9. PubMed ID: 17963413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coupling of biotin-(poly(ethylene glycol))amine to poly(D,L-lactide-co-glycolide) nanoparticles for versatile surface modification.
    Weiss B; Schneider M; Muys L; Taetz S; Neumann D; Schaefer UF; Lehr CM
    Bioconjug Chem; 2007; 18(4):1087-94. PubMed ID: 17590034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S; Poulin S; Hildgen P
    J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures.
    Costantino L; Gandolfi F; Bossy-Nobs L; Tosi G; Gurny R; Rivasi F; Vandelli MA; Forni F
    Biomaterials; 2006 Sep; 27(26):4635-45. PubMed ID: 16716395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEG-PLA block copolymer as potential drug carrier: preparation and characterization.
    Ben-Shabat S; Kumar N; Domb AJ
    Macromol Biosci; 2006 Dec; 6(12):1019-25. PubMed ID: 17128420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
    McCarron PA; Marouf WM; Donnelly RF; Scott C
    J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microporous structure and drug release kinetics of polymeric nanoparticles.
    Sant S; Thommes M; Hildgen P
    Langmuir; 2008 Jan; 24(1):280-7. PubMed ID: 18052222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer.
    Shan X; Liu C; Yuan Y; Xu F; Tao X; Sheng Y; Zhou H
    Colloids Surf B Biointerfaces; 2009 Sep; 72(2):303-11. PubMed ID: 19450955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A; Siegel SJ; Winey KI
    Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
    Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
    Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Architecture control of three-dimensional polymeric scaffolds for soft tissue engineering. I. Establishment and validation of numerical models.
    Cao Y; Davidson MR; O'Connor AJ; Stevens GW; Cooper-White JJ
    J Biomed Mater Res A; 2004 Oct; 71(1):81-9. PubMed ID: 15368257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
    Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
    J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors.
    Chung YI; Tae G; Hong Yuk S
    Biomaterials; 2006 Apr; 27(12):2621-6. PubMed ID: 16360204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new generation of polymer nanoparticles for drug delivery.
    Chauvierre C; Vauthier C; Labarre D; Couvreur P; Marden MC; Leclerc L
    Cell Mol Biol (Noisy-le-grand); 2004 May; 50(3):233-9. PubMed ID: 15209344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcumin.
    Wang H; Jia Y; Hu W; Jiang H; Zhang J; Zhang L
    Pharm Dev Technol; 2013; 18(3):694-700. PubMed ID: 22676257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.
    Esmaeili F; Hosseini-Nasr M; Rad-Malekshahi M; Samadi N; Atyabi F; Dinarvand R
    Nanomedicine; 2007 Jun; 3(2):161-7. PubMed ID: 17468055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental design and multivariate analysis for optimizing poly(D,L-lactide-co-glycolide) (PLGA) nanoparticle synthesis using molecular micelles.
    Ganea GM; Sabliov CM; Ishola AO; Fakayode SO; Warner IM
    J Nanosci Nanotechnol; 2008 Jan; 8(1):280-92. PubMed ID: 18468072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.